Bioequivalence and Bioavailability Forum 10:29 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

New EMA guideline: Handling and shipping of IMPs [BE/BA News]

posted by Helmut Homepage - Vienna, Austria, 2018-05-24 15:45  - Posting: # 18814
Views: 672

Dear all,

today the EMA published the “Draft guideline on the responsibilities of the sponsor with regard to handling and shipping of investigational medicinal products for human use in accordance with Good Clinical Practice and Good Manufacturing Practice”. End of consultation is on 31 August 2018.

Have also a look at the applicable guidelines on Good Distribution Practice (GDP):

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,761 posts in 3,996 threads, 1,265 registered users;
online 17 (0 registered, 17 guests [including 11 identified bots]).

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed